USPTO serial 86838031
ATRECA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- KHAN, AHSEN M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ATRECA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Redwood City, CA
Redwood City, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
R. Gwen Peterson
R. GWEN PETERSON KILPATRICK TOWNSEND & STOCKTON LLPTWO EMBARCADERO CENTER, 8TH FLOORSAN FRANCISCO, CA 94111-3834UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medical laboratory, or research use; biological tissue cultures for research and scientific diagnosis use; antibodies reagents for research and scientific diagnosis use; combinations of biological tissue cultures for research and scientific diagnosis use; combinations of antibody reagents for research and scientific diagnosis use; kits containing buffers and chemical reagents for use in molecular biology research | ACTIVE | — |
| 005 | Diagnostic preparations and diagnostic kits comprised of buffers and reagents for medical use, for predicting the response of patients to therapeutics; biologics for medical use, namely, biological preparation for the treatment of infectious disease; biologics for medical use, namely, biological preparation for the treatment of cancer; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologics for medical use, namely, biological preparation for the treatment of animal diseases; biologics, namely, biological tissue cultures for medical diagnosis; biologics, namely, antibodies for medical diagnosis; biologics, namely, vaccines for medical diagnosis, research and scientific diagnosis; combinations of biologics for medical use, namely, biological preparation for the treatment of infectious disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cancer; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; combinations of biologics for medical use, namely, biological preparation for the treatment of animal diseases; combinations of biologics, namely, biological tissue cultures, antibodies, and vaccines, for medical diagnosis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 12, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 5, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 4, 2018 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Dec 4, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 26, 2018 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 26, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 14, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 12, 2018 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 12, 2018 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 12, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 16, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 12, 2018 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 12, 2018 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 12, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 8, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 5, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 5, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 5, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 16, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 14, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 14, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 14, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 12, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 17, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 17, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 27, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 24, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 24, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 24, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 24, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 24, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 22, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 8, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 7, 2015 | NWAP | NEW APPLICATION ENTERED | — |